SHM_comments_J1visa_DHS_Oct2020_FINAL.pdf

SHM_COVID-19_PolicyLetter_4_1_20(FINAL).pdf

SHM_CY2021_PFS_FINAL_10_5_2020.pdf

SHM_letter_support_HR5795.pdf

SHM Submits a Letter of Support for Opioid Legislation _blank

SHM_MainstreamingAddictionTreatmentAct2021_Tonko_Final.pdf

SHM_OPPS_2019_FINAL9.25.18.pdf

SHM submits comments on the HCAHPS survey pain communication questions in the 2019 Outpatient Prospective Payment System Rule.

SHM_OPPS_2021_Final.pdf

SHM_SFC_OpioidResponse021618.pdf

SHM Opioid Response - Senate Committee on Finance

SHMHospitalHarmComments_Oct302018.pdf

SHM sends comments to CMS on the Severe Hyperglycemia and Medication-Related Bleeding Hospital Harm Measures.

Sign-on letter to Acting Secretary Cochran on Practice Guidelines for Prescribing Buprenorphine - 01.27.21.pdf